CX Institutional

Position in MRNA — Moderna, Inc.

CIK 1737089 AUBURN, IN

Position in MRNA

as of Jun 30, 2026 · filed Jul 2, 2026 Compact

Position Value

$610,661

+$209,189 QoQ

Shares Held

8,720

+10.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#24

of 87 holders

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Jun 30, 2026

CX Institutional holds $30,767,447 across 22 Biotechnology names. MRNA ranks #7 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HRMY	Harmony Biosciences Holdings, Inc.	259,496	$9,448,249
2	INVA	Innoviva, Inc.	280,240	$6,364,250
3	INCY	Incyte Corp	48,034	$5,445,134
4	EXEL	Exelixis, Inc.	91,216	$4,963,062
5	JAZZ	Jazz Pharmaceuticals plc	9,216	$2,220,779
6	VRTX	Vertex Pharmaceuticals Inc / Ma	1,838	$912,989
7	MRNA	Moderna, Inc. This page	8,720	$610,661
8	TECH	BIO-TECHNE Corp	4,807	$339,614

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$610,661	8,720	+10.3%	Shares	Sole	2026-07-02
2026-03-31	$401,472	7,903	-2.7%	Shares	Sole	2026-04-06
2025-12-31	$239,488	8,121	+14.0%	Shares	Sole	2026-02-02
2025-09-30	$183,935	7,121	+589.4%	Shares	Sole	2025-10-23
2025-06-30	$28,500	1,033	+1129.8%	Shares	Sole	2025-07-16
2025-03-31	$2,381	84	-98.1%	Shares	Sole	2025-04-15
2024-06-30	$526,893	4,437	+49.6%	Shares	Sole	2024-07-11
2024-03-31	$316,056	2,966	+24.9%	Shares	Sole	2024-04-15
2023-12-31	$236,193	2,375	+6.3%	Shares	Sole	2024-01-12
2023-03-31	$343,097	2,234	+80.6%	Shares	Sole	2023-05-04
2022-12-31	$222,189	1,237	+1927.9%	Shares	Sole	2023-02-03
2022-06-30	$8,713	61	+369.2%	Shares	Sole	2022-08-02
2021-09-30	$5,003	13	—	Shares	Sole	2021-11-10
No filing history on record for this holder in this stock.